Down-regulation of NOSII gene expression by iontophoresis of anti-sense oligonucleotide in endotoxin-induced uveitis

被引:36
作者
Voigt, M
de Kozak, Y
Halhal, M
Courtois, Y
Behar-Cohen, F
机构
[1] INSERM, U450, F-75270 Paris 6, France
[2] Assoc Claude Bernard, Paris, France
[3] Hop Hotel Dieu, Dept Ophthalmol, Paris, France
[4] Rothschild Fdn, Paris, France
关键词
iontophoresis; anti-sense oligonucleotide; NOSII; endotoxin-induced uveitis;
D O I
10.1016/S0006-291X(02)00656-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcorneoscleral iontophoresis was used to enhance ocular penetration of a 21-bp NH2, protected anti-NOSII oligonucleotides (ODNs) (fluorescein or infrared-41 labeled) in Lewis rats. Both histochemical localization and acrylamide sequencing gels were used. To evaluate the potential to down-regulate NOSH expression in the rat model of endotoxin-induced uveitis (EIU), anti-sense NOSH ODN, scrambled ODN or saline were iontophorezed into these animals' eyes. Iontophoresis facilitated the penetration of intact ODNs into the intraocular tissues of the rat eye and only the eyes receiving ODNs and electrical current demonstrated intact ODNs within the ocular tissues of both segments of the eye. Iontophoresis of anti-NOSII ODN significantly down-regulated the expression of NOSH expression in iris/ciliary body compared to the saline or scrambled ODN treated eyes. Nitrite production was also significantly reduced in the anti-NOSH applied eyes compared to those treated with saline. Using this system, intraocular delivery of ODNs can be significantly enhanced increasing the potential for successful gene therapy for human eye diseases. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:336 / 341
页数:6
相关论文
共 22 条
[11]   MECHANISMS OF THE INHIBITION OF REVERSE TRANSCRIPTION BY ANTISENSE OLIGONUCLEOTIDES [J].
BOIZIAU, C ;
THUONG, NT ;
TOULME, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (02) :768-772
[12]   Evaluation of retinal toxicity and efficacy of anti-cytomegalovirus and anti-herpes simplex virus antiviral phosphorothioate oligonucleotides ISIS 2922 and ISIS 4015 [J].
FloresAguilar, M ;
Besen, G ;
Vuong, C ;
Tatebayashi, M ;
Munguia, D ;
Gangan, P ;
Wiley, CA ;
Freeman, WR .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (06) :1308-1316
[13]  
Glover JM, 1997, J PHARMACOL EXP THER, V282, P1173
[14]  
GOUREAU O, 1995, J IMMUNOL, V154, P6518
[15]   LONG-TERM INTRAVITREAL GANCICLOVIR THERAPY FOR CYTOMEGALO-VIRUS RETINOPATHY [J].
HEINEMANN, MH .
ARCHIVES OF OPHTHALMOLOGY, 1989, 107 (12) :1767-1772
[16]   FOSCARNET TREATMENT OF CYTOMEGALO-VIRUS RETINITIS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
JACOBSON, MA ;
ODONNELL, JJ ;
MILLS, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :736-741
[17]  
Jacquemin E, 1996, INVEST OPHTH VIS SCI, V37, P1187
[18]  
Mandai M, 1996, INVEST OPHTH VIS SCI, V37, P826
[19]   Cellular localisation and dynamics of nitric oxide synthase expression in the rat anterior segment during endotoxin-induced uveitis [J].
McMenamin, PG ;
Crewe, JM .
EXPERIMENTAL EYE RESEARCH, 1997, 65 (02) :157-164
[20]   Targeted delivery of an antisense oligonucleotide in the retina: Uptake, distribution, stability, and effect [J].
Rakoczy, PE ;
Lai, MC ;
Watson, M ;
Seydel, U ;
Constable, I .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1996, 6 (03) :207-213